SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. (2395) Other
Market cap
¥58.9B
P/E ratio
16.5x
Provides drug development testing services to pharmaceutical companies and operates innovative intranasal drug delivery technology through spinout companies.
| 2012/03 | 2013/03 | 2014/03 | 2015/03 | 2016/03 | 2017/03 | 2018/03 | 2019/03 | 2020/03 | 2021/03 | 2022/03 | 2023/03 | 2024/03 | 2025/03 | |
| Return on Assets | - | - | - | - | 6 | 1.7 | -2.8 | 3.5 | 5.7 | 9.7 | 18.8 | 12.6 | 8.3 | 5.8 |
| Return on equity (%) | - | - | - | |||||||||||
| Employees | 1,691 | 1,777 | 1,866 | 1,877 | 1,630 | 1,506 | 1,385 | 935 | 985 | 986 | 994 | 1,208 | 1,341 | 1,436 |
| Total payout ratio | - | - | - | -0 | - | - | - | - | - | - | - | - | - | 42.6 |